Healthcare
Welcia Holdings Co., Ltd.(WLCGF)
Live Price
Offline$16.41
+0.00% today
Window Change
+0.00%
Window
Jun 23, 2025 โ Apr 6, 2026
- Market Cap
- $3.42B
- Revenue Growth
- +5.6%
- EPS Growth
- -43.5%
- Dividend Yield
- 0.6%
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 198 bars ยท Jun 23, 2025 โ Apr 6, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Welcia Holdings Co., Ltd. (WLCGF) is a Healthcare stock with a market cap of $3.42B and listed on OTC. The stock last traded around $16.41 and up 0.0% across the available one-year price window (Jun 23, 2025 โ Apr 6, 2026). Baseline metrics include revenue growth of +5.6%, EPS growth of -43.5%, a dividend yield of 0.6%. What stands out right now is revenue +5.6%, EPS -43.5%, free cash flow +25.5% with operating margin 3.0% and ROIC 6.7%. The dividend is present but secondary, with a yield around 0.6%. Valuation already assumes a fairly strong business story at P/E 34.3 and price/sales 0.5. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines WLCGF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+5.6% vs +7.6% peer median
Operating Margin
Below sector median
+3.0% vs +19.4% peer median
P/E
Below sector median
34.3 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 9, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +5.6% and EPS is at -43.5%, with operating margin around 3.0%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 0.6%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Jan 6, 2026 | โ | +0.0% | +0.0% | +0.0% |
2025 Jul 8, 2025 | +58.9% | +0.0% | +0.0% | +0.0% |
2025 Apr 11, 2025 | -62.6% | +0.0% | +0.0% | +0.0% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
WLCGF
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
WLCGF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for WLCGF and SPY.
Company Overview
Welcia Holdings Co., Ltd.
Other OTC
Welcia Holdings Co., Ltd., together with its subsidiaries, operates a chain of drug stores with dispensing pharmacies in Japan. Its stores primarily sell OTC, healthcare/nursing care, baby, and health food products, as well as dispensing, cosmetics, household goods, food, and other products. The company also offers counseling, late-night, and long-term care services, as well as home-visit bathing and nursing care support services. In addition, it rents and sells welfare equipment; and provides housing services for elderly people. As of February 28, 2022, the company operated 2,468 stores. Welcia Holdings Co., Ltd. was incorporated in 2008 and is headquartered in Tokyo, Japan. Welcia Holdings Co., Ltd. is a subsidiary of Aeon Co., Ltd.
- Leadership
- Hideaki Kirisawa
- IPO Date
- Dec 14, 2021
- Employees
- 15.3k
- Street Address
- 2-2-15, Sotokanda
- Mailing
- Tokyo, 101-0021
- Region
- Tokyo, JP
- Reporting Currency
- USD
- Investor Line
- 81 3 5207 5878
- Last Updated
- May 6, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 34.3
- EV/EBITDA
- 10.8
- Price/Sales
- 0.5
- Price/Book
- 2.5
Growth
- Revenue
- +5.6%
- EPS
- -43.5%
- Free Cash Flow
- +25.5%
Profitability
- Gross Margin
- 30.3%
- Operating Margin
- 3.0%
- Net Margin
- 1.4%
- ROE
- 7.6%
- ROIC
- 6.7%
Balance Sheet
- Debt/Equity
- 0.27
- Current Ratio
- 1.18
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.